发明名称 Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders
摘要 The present invention discloses compounds according to Formula I:;;Wherein R1a, R1b, R2, R4, R5, R6a, R6b, R7, R8, W, X, Cy, and the subscript a are as defined herein.;The present invention relates to compounds inhibiting autotaxin (NPP2 or ENPP2), methods for their production, pharmaceutical compositions comprising the same, and methods of treatment using the same, for the prophylaxis and/or treatment of diseases involving fibrotic diseases, proliferative diseases, inflammatory diseases, autoimmune diseases, respiratory diseases, cardiovascular diseases, neurodegenerative diseases, dermatological disorders, and/or abnormal angiogenesis associated diseases by administering the compound of the invention.
申请公布号 US9249141(B2) 申请公布日期 2016.02.02
申请号 US201414572870 申请日期 2014.12.17
申请人 GALAPAGOS NV 发明人 Desroy Nicolas;Heckmann Bertrand;Brys Reginald Christophe Xavier;Joncour Agnès Marie;Peixoto Christophe;Bock Xavier Marie
分类号 A61K31/4353;C07D401/04;C07D471/04;A61K31/437;A61K31/496;A61K31/506;A61K31/5377;A61K31/541;A61K31/444;A61K31/4545 主分类号 A61K31/4353
代理机构 Heslin Rothenberg Farley & Mesiti P.C. 代理人 Heslin Rothenberg Farley & Mesiti P.C.
主权项 1. A compound of the formula: or a pharmaceutically acceptable salt, or a solvate, or a pharmaceutically acceptable salt of a solvate thereof.
地址 Mechelen BE